-
Name:Tenofovir alafenamide
Catalog No.:B0007
Structure:
Chemical Properties Cas No.:379270-37-8 Purity Limit: Synonyms:GS-7340 Molecular Weight:476.79 Formula:C21H29N6O5P Storage: Solubility:
Shipping Condition
Quality Control & MSDS
Description Tenofovir alafenamide, also known as GS-7340, is a nucleotide reverse transcriptase inhibitor and a novel prodrug of tenofovir. It is under development by Gilead Sciences for use in the treatment of HIV infection. Closely related to the commonly used reverse-transcriptase inhibitor tenofovir disoproxil fumarate (Viread), Tenofovir alafenamide has greater antiviral activity and better distribution into lymphoid tissues than that agent. Gilead has announced a phase 3 clinical trial evaluating a single-tablet regimen combining GS-7340 with cobicistat, emtricitabine and elvitegravir and plans to coformulate the drug with cobicistat, emtricitabine and the protease inhibitor darunavir. In a 48 week study comparing Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate, the results showed the prodrug to be non inferior to the established agent, but at much lower dosages and with lower incidence of adverse side effects such as impaired kidney function
References Related products
- Telaprevir
- Ixazomib
- Odanacatib
- L685458
- Emricasan
- Belnacasan
- Cobicistat
- Ispinesib
- Carfilzomib
- Talabostat
Tel: +86-411-39042497
sales@alphabiopham.com
Contact us now!
We'll offer you the best prices